Proteonomix, Inc. (OTCPK:PROT)
PROT, a biotechnology company, engages in the development of stem cell therapies primarily for the treatment of diabetes and cardiac therapy, as well as offers cosmeceutical products. The stem cell therapy involves the introduction of healthy new stem cells to repair and replace damaged or lost cells. It offers product for the treatment of anti-aging and damaged skin. PROT develops cosmetic products using its technologies, Secreted Matrix and Matrix NC-138 that is a stem cell derived proteins technology. PROT is also involved in the operation of retail Web site, Proteoderm.com to sell its anti-aging line of skin care products; develops therapeutic modalities for the treatment of cardiovascular disease; and engages in the reproductive tissue banking, including sperm, ova, ovarian tissue, and testicular tissue. In addition, PROT develops intellectual properties for patent applications, including a medium and scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a cord blood banking cryopreservation bag, and a device to eliminate malformed stem cells via filtration. Further, PROT is developing pre-clinical-stage therapeutic agents and treatments for cancer, diabetes, heart, lung, and kidney diseases, as well as for stem cell bone marrow and organ transplants. PROT was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. PROT was founded in 2005 and is based in Mountainside, New Jersey.
PROT, a biotechnology company focused on developing therapeutics based upon human cells and their derivatives, announced further developments with its Joint Venture Company, XGEN Medical LLC ("XGen") towards implementing operations in the United Arab Emirates (U.A.E.).
During initial meetings, it was mutually decided to open a local subsidiary corporation in the Dubai free zone. This wholly owned subsidiary will be the vehicle to conduct business in the GCC countries. XGen has filed the corporate papers and has established banking relations with a local bank both for receipt of the initial investment of $5 million and towards further financing expanded services in the region. The Ramadan holiday has slowed progress slightly on these corporate formalities, but full operation of the subsidiary and bank accounts are expected to complete within 30 days.
To learn more about PROT visit: http://www.proteonomix.com
SeraCare Life Sciences, Inc. (NASDAQ:SRLS)
SRLS, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, recently reported operational and financial results for its third quarter of fiscal year 2010, ended June 30, 2010. The third quarter of fiscal year 2010 marks SRLS’s fifth consecutive quarter of profitability.
SRLS, a life sciences company, provides products and services to facilitate the discovery, development, and production of human and animal diagnostics, and therapeutics. SRLS Life Sciences sells its products through direct sales force and independent distributors primarily in the United States, Europe, and Asia. SRLS was founded in 1984 and is headquartered in Milford, Massachusetts.
To learn more about SRLS visit: http://www.seracare.com
Service Corporation International (NYSE:SCI)
SCI, the largest provider of deathcare products and services in North America, recently declared that its Board of Directors has approved a quarterly cash dividend of four cents per share of common stock. The quarterly cash dividend is payable on October 29, 2010 to shareholders of record at the close of business on October 15, 2010. While SCI intends to pay regular quarterly cash dividends for the foreseeable future, all subsequent dividends, and the establishment of record and payment dates, are subject to final determination by the Board of Directors each quarter after its review of SCI's financial performance.
SCI provides deathcare products and services in the United States, Canada, and Germany. As of December 31, 2009, SCI operated 1,254 funeral service locations and 372 cemeteries, including 208 combination locations, covering 43 states in the United States, 8 Canadian provinces, the District of Columbia, and Puerto Rico, as well as 12 funeral homes in Germany. SCI was founded in 1962 and is headquartered in Houston, Texas.
To learn more about SCI visit: http://www.sci-corp.com
SERVIDYNE, INC. (Nasdaq:SERV)
SERV, an energy efficiency and demand response company, recently reported that its SEC Form 10-Q Quarterly Report, reflects that SERV's consolidated revenues from continuing operations for the fiscal first quarter ended July 31, 2010, were approximately $5.1 million, representing year-over-year growth of 24%. At SERV’s core Building Performance Efficiency (“BPE”) Segment, first quarter revenues exceeded $4.8 million, an increase of 25% over the first quarter of last year, including a 50% year-over-year increase in Energy Savings Projects revenues.
SERV, through its subsidiaries, provides energy efficiency and demand response solutions, sustainability programs, and other products and services in the United States and internationally. SERV was formerly known as Abrams Industries, Inc. and changed its name to Servidyne, Inc. on July 13, 2006. SERV was founded in 1925 and is headquartered in Atlanta, Georgia.
To learn more about SERV visit: http://www.servidyne.com
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (OTCPK:PROT)